U.S. flag

An official website of the United States government

NM_170784.3(MKKS):c.830T>C (p.Leu277Pro) AND Bardet-Biedl syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 14, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003230348.1

Allele description [Variation Report for NM_170784.3(MKKS):c.830T>C (p.Leu277Pro)]

NM_170784.3(MKKS):c.830T>C (p.Leu277Pro)

Gene:
MKKS:MKKS centrosomal shuttling protein [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20p12.2
Genomic location:
Preferred name:
NM_170784.3(MKKS):c.830T>C (p.Leu277Pro)
HGVS:
  • NC_000020.11:g.10412685A>G
  • NG_009109.2:g.26534T>C
  • NM_018848.3:c.830T>C
  • NM_170784.3:c.830T>CMANE SELECT
  • NP_061336.1:p.Leu277Pro
  • NP_740754.1:p.Leu277Pro
  • NC_000020.10:g.10393333A>G
  • NM_018848.2:c.830T>C
  • NM_170784.3:c.830T>C
  • Q9NPJ1:p.Leu277Pro
Protein change:
L277P; LEU277PRO
Links:
UniProtKB: Q9NPJ1#VAR_009884; OMIM: 604896.0008; dbSNP: rs74315398
NCBI 1000 Genomes Browser:
rs74315398
Molecular consequence:
  • NM_018848.3:c.830T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_170784.3:c.830T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Bardet-Biedl syndrome (BBS)
Identifiers:
MONDO: MONDO:0015229; MedGen: C0752166; Orphanet: 110; OMIM: PS209900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003928492Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Apr 14, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome.

Katsanis N, Beales PL, Woods MO, Lewis RA, Green JS, Parfrey PS, Ansley SJ, Davidson WS, Lupski JR.

Nat Genet. 2000 Sep;26(1):67-70.

PubMed [citation]
PMID:
10973251

Functional analyses of variants reveal a significant role for dominant negative and common alleles in oligogenic Bardet-Biedl syndrome.

Zaghloul NA, Liu Y, Gerdes JM, Gascue C, Oh EC, Leitch CC, Bromberg Y, Binkley J, Leibel RL, Sidow A, Badano JL, Katsanis N.

Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10602-7. doi: 10.1073/pnas.1000219107. Epub 2010 May 24.

PubMed [citation]
PMID:
20498079
PMCID:
PMC2890780
See all PubMed Citations (6)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003928492.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

Variant summary: MKKS c.830T>C (p.Leu277Pro) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 251158 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in MKKS causing Bardet-Biedl Syndrome (6.4e-05 vs 0.00076), allowing no conclusion about variant significance. c.830T>C has been reported in the literature in both compound heterozygous and homozygous individuals affected with Bardet-Biedl Syndrome and has been reported to segregate with disease in related individuals (e.g., Katsanis_2000, Pereiro_2011, Groopman_2019). These data indicate that the variant is likely to be associated with disease. Several publications report experimental evidence evaluating an impact on protein function, finding that the variant behaved a a null allele in a zebrafish model of gastrulation phenotypes (Zaghloul_2010) and greatly disrupted MKKS protein interactions (e.g., Rachel_2012, Seo_1010). Five ClinVar submitters (evaluation after 2014) have cited the variant with conflicting assessments; four submitters classified the variant as pathogenic/likely pathogenic, and one classified it as uncertain significance. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024